APRIL EBERSOLE: Open Payments
NPI 1447245956 · COOKEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,456 in 80 payments from 12 companies in 2025. Trend: 2023 $42 · 2024 $280 · 2025 $1,456
Food & beverage: $1,456
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $294 |
| Lundbeck LLC | 12 | $241 |
| Vanda Pharmaceuticals Inc. | 11 | $216 |
| Axsome Therapeutics, Inc. | 11 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $128 |
| Otsuka America Pharmaceutical, Inc. | 6 | $126 |
| Neurocrine BioSciences, Inc. | 4 | $109 |
| Alkermes, Inc. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
Products named: REXULTI, VRAYLAR, Auvelity, CAPLYTA, FANAPT, INGREZZA, HETLIOZ, ARISTADA.
Industry payments across TN — which companies pay providers there.
